News Karnataka
Friday, January 27 2023
North America

US: Novavax Covid-19 vaccine Adjuvanted gets expanded approval

gets expanded approval in US
Photo Credit : IANS

Washington: Novavax says the US Food and Drug Administration (FDA) has granted expanded emergency use authorisation for its Covid-19 vaccine Adjuvanted for adolescents aged between 12-17 years.

The US company said the vaccine was the first protein-based Covid-19 jab authorised in the US, dpa news agency reported.

Doses of the Adjuvanted are available for use in adolescents upon the Centers for Disease Control and Prevention’s (CDC) recommendation, the company noted.

In July 2022, the FDA had granted emergency use authorisation for a two-dose primary series in adults aged 18 years and older, followed by a recommendation from the CDC Advisory Committee on Immunisation Practices, and endorsement from the CDC.

Share this:
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Leave a Reply

Your email address will not be published. Required fields are marked *

Find the best odds at 10Cric and ipl betting 2021! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp